The use of opioid medications for treating acute migraine is controversial. Drugs in this class are not considered first-line treatment for migraine but are prescribed for many migraineurs to eliminate the pain of an acute attack.
Well-known risks associated with opioids include medication overuse headaches, drug dependence and abuse. Continue Reading
MIDAS stands for Migraine Disability Assessment Questionnaire. It was developed to measure headache-related disability in three areas:
Paid work and education (school/college)
Family, social and leisure activities
By measuring the number of days missed in these activity areas due to migraine, the MIDAS tool can “improve migraine care by getting treatment right the first time a patient consults” with his or her healthcare provider.
The MIDAS score looks at the patients’ medical needs and helps the healthcare provider to determine the appropriate treatment at the first consultation.